Advertisement

Drugs

, Volume 46, Supplement 1, pp 34–39 | Cite as

Effects of Nimesulide and Naproxen on the Degradation and Metalloprotease Synthesis of Human Osteoarthritic Cartilage

  • Jean-Pierre Pelletier
  • J. Martel-Pelletier
Article

Summary

The aim of this study was to examine the effects of 2 nonsteroidal anti-inflammatory drugs (NSAIDs), nimesulide and naproxen, on the proteoglycan matrix breakdown and metalloprotease synthesis of human osteoarthritic cartilage. The results showed that, under in vitro conditions, these 2 NSAIDs could significantly reduce both the degradation of proteoglycan and stromelysin synthesis. However, only nimesulide had the ability to significantly reduce collagenase synthesis. The effectiveness of these drugs on the natural course of osteoarthritis remains to be established by clinical studies.

Keywords

Osteoarthritis Articular Cartilage Hyaluronic Acid Naproxen Nimesulide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, et al. ARA Diagnostic Subcommitee for OA. Development of criteria for classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis and Rheumatism 29: 1039–1049, 1986PubMedCrossRefGoogle Scholar
  2. Campbell IK, Roughley PJ, Mort JS. The action of human articular cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro. Biochemical Journal 237: 117–122, 1986Google Scholar
  3. Cawston TE, Barrett AJ. A rapid and reproducible assay for collagenase using (1-14C)-acetylated collagen. Analytical Biochemistry 99: 340–345, 1979PubMedCrossRefGoogle Scholar
  4. Chavira Jr R, Burnett TJ, Hageman JH. Assaying proteinases with azocoll. Analytical Biochemistry 136: 446–450, 1984PubMedCrossRefGoogle Scholar
  5. Colombo C, Bulter M, Hickman L, Sellewyn M, Chart J, et al. A new model of osteoarthritis in rabbits. II. Evaluation of anti-osteoarthritic effects of selected antirheumatic drugs administered systemically. Arthritis and Rheumatism 26: 1132–1139, 1983PubMedCrossRefGoogle Scholar
  6. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner Jr JF. Evidence for metalloproteinase and metalloproteinase inhibitor (TIMP) imbalance in human osteoarthritic cartilage. Journal of Clinical Investigation 84: 678–685, 1989PubMedCrossRefGoogle Scholar
  7. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connective Tissue Research 9: 247–248, 1982PubMedCrossRefGoogle Scholar
  8. Hess EV, Herman JH. Cartilage metabolism and anti-inflammatory drugs in osteoarthritis. American Journal of Medicine 81 (Suppl.): 36–43, 1986PubMedGoogle Scholar
  9. Maier R, Wilhelmi G. Preclinical investigations of drug effects in models of osteoarthritis. In Munthe E, Bjelle A (Eds) Effects of drugs on osteoarthrosis. Proceedings of the 10th European Congess of Rheumatology, Moscow, 1983, pp. 90–96, Hans Huber, Berne, 1984Google Scholar
  10. Mankin HJ. The reaction of articular cartilage to injury and osteoarthritis (second of two parts). New England Journal of Medicine 291: 1335–1340, 1974PubMedCrossRefGoogle Scholar
  11. Mankin HJ, Treadwell BV. Osteoarthritis: a 1987 update. Bulletin on the Rheumatic Diseases 36: 1–10, 1986PubMedGoogle Scholar
  12. Martel-Pelletier J, Pelletier JP, Cloutier JM, Woessner Jr JF. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis and Rheumatism 27: 305–312, 1984PubMedCrossRefGoogle Scholar
  13. Martel-Pelletier J, Pelletier JP, Malemud CJ. Activation of neutral metalloprotease in human osteoarthritic knee cartilage: evidence for degradation in the core protein of sulphated proteoglycan. Annals of the Rheumatic Diseases 47: 801–808, 1988PubMedCrossRefGoogle Scholar
  14. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochemical Journal 248: 265–258, 1987PubMedGoogle Scholar
  15. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage. Journal of Rheumatology 16: 646–655, 1989PubMedGoogle Scholar
  16. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vitro effects of NSAIDs and corticosteroids on the synthesis and secretion of interleukin-1 by human osteoarthritic synovial membranes. Agents and Actions, in press, 1993Google Scholar
  17. Pelletier JP, Martel-Pelletier J, Altman RD, Ghandur-Mnaymneh L, Howell DS, et al. Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Ppnd-Nuki dog model of osteoarthritis. Arthritis and Rheumatism 26: 866–874, 1983aPubMedCrossRefGoogle Scholar
  18. Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis J, et al. Collagenase and collagenolytic acivity in human osteoarthritic cartilage. Arthritis and Rheumatism 26: 63–68, 1983bPubMedCrossRefGoogle Scholar
  19. Pelletier JP, Martel-Pelletier J. In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on human osteoarthritic cartilage degradation and synovial collagenase synthesis. Drugs 35 (Suppl. 1): 42–45, 1988PubMedCrossRefGoogle Scholar
  20. Pelletier JP, Roughley PJ, DiBattista JA, McCollum R, Martel-Pelletier J. Are cytokines involved in osteoarthritis pathophysiology. Seminars in Arthritis and Rheumatism 20 (Suppl. 2): 12–25, 1991PubMedCrossRefGoogle Scholar
  21. Sokoloff L. Osteoarthritis as a remodeling process. Journal of Rheumatology 14: 7–10, 1987PubMedGoogle Scholar
  22. Tyler JA. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochemical Journal 225: 493–507, 1985PubMedGoogle Scholar
  23. Vignon E, Mathieu P, Broquet P, Louisot P, Richard M. Cartilage degradative enzymes in human osteoarthritis: effect of a non-steroidal antiinflammatory drug administered orally. Seminars in Arthritis and Rheumatism 19 (Suppl.): 26–29, 1990PubMedCrossRefGoogle Scholar
  24. Vignon E, Mathieu P, Louisot P, Richard M. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis and Rheumatism 34: 1332–1335, 1991PubMedCrossRefGoogle Scholar
  25. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL. Isolation of an interleukin-1 like factor from human joint effusions. Arthritis and Rheumatism 26: 975–983, 1983PubMedCrossRefGoogle Scholar
  26. Wood DD, Ihrie EJ, Hamerman D. Release of interleukin-1 from human synovial tissue in vitro. Arthritis and Rheumatism 28: 853–862, 1985PubMedCrossRefGoogle Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • Jean-Pierre Pelletier
    • 1
  • J. Martel-Pelletier
    • 1
  1. 1.University of Montreal, Rheumatic Disease Unit, Notre-Dame Hospital Research CentreMontrealCanada

Personalised recommendations